Cowen Starts NantHealth (NH) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Canaccord Genuity Starts NantHealth (NH) at Buy
June 27, 2016 6:56 AM EDTCanaccord Genuity initiated coverage on NantHealth (NASDAQ: NH) with a Buy rating and a price target of $17.
For an analyst ratings summary and ratings history on NantHealth click here. For more ratings news on NantHealth click here.
Shares of NantHealth closed at $12.71 yesterday.
... MoreFBR Capital Starts NantHealth (NH) at Outperform
June 27, 2016 6:28 AM EDTFBR Capital initiates coverage on NantHealth (NASDAQ: NH) with a Outperform rating and a price target of $18.00.
Analyst Steven Halper commented, "We initiate coverage of NantHealth, LLC (NH) with an Outperform rating. NantHealth is an evidence-based, personalized healthcare company that aims to improve patient... More
